Travere Therapeutics Inc.

17.95
0.51 (2.92%)
At close: Apr 02, 2025, 3:59 PM
17.43
-2.90%
Pre-market: Apr 03, 2025, 06:10 AM EDT

Travere Therapeutics Stock Forecast

Stock Price Forecast

The 14 analysts with 12-month price forecasts for TVTX stock have an median target of 32, with a low estimate of 20 and a high estimate of 45. The median target predicts an increase of 78.27% from the current stock price of 17.95.

Target Low Average Median High
Price $20 $33 $32 $45
Change 11.42% 83.84% 78.27% 150.70%

Latest Analyst Insight Report

Scotiabank has reaffirmed a Sector Outperform rati... Unlock content with Pro Subscription

Updated Feb 12, 2025

Rating Sep 24Oct 24Nov 24Jan 25Feb 25Apr 25
Strong Buy 420121
Buy 762040
Hold 001000
Sell 000000
Strong Sell 000000
Total 11 8 3 1 6 1

Financial Forecast this Year

Revenue This Year
387.19M
from 233.18M
Increased by 66.1%
Revenue Next Year
590.73M
from 387.19M
Increased by 52.6%
EPS This Year
-1.2
from -4.08
Increased by 70.6%
EPS Next Year
0.84
from -1.2
Increased by 30.0%